scorecardresearchPfizer Share Price Live NSE, BSE, Today - Pfizer Stock Price
Mintgenie
Asian Paints2,825.00-18.55 (-0.65%)
Axis Bank1,052.80-5.75 (-0.54%)
Bajaj Finance6,947.35-127.65 (-1.80%)
Bajaj Finserv1,619.05-38.25 (-2.31%)
Bharti Airtel1,212.55-12.50 (-1.02%)
HCL Technologies1,476.30-29.15 (-1.94%)
HDFC Bank1,509.4014.45 (0.97%)
Hindustan Unilever2,220.9026.30 (1.20%)
ICICI Bank1,067.55-11.25 (-1.04%)
ITC425.950.05 (0.01%)
Indusind Bank1,490.75-48.05 (-3.12%)
Infosys1,414.75-53.55 (-3.65%)
Kotak Mahindra Bank1,795.40-2.45 (-0.14%)
Larsen & Toubro3,545.15-55.70 (-1.55%)
Mahindra & Mahindra2,029.30-20.95 (-1.02%)
Maruti Suzuki India12,503.1576.60 (0.62%)
NTPC359.40-1.95 (-0.54%)
Nestle India2,547.25-4.70 (-0.18%)
Power Grid Corporation Of India274.350.20 (0.07%)
Reliance Industries2,934.451.55 (0.05%)
State Bank Of India751.90-4.95 (-0.65%)
Sun Pharmaceutical Industries1,536.95-4.20 (-0.27%)
Tata Consultancy Services3,872.30-69.35 (-1.76%)
Tata Motors992.45-6.25 (-0.63%)
Tata Steel160.05-0.85 (-0.53%)
Tech Mahindra1,196.00-23.20 (-1.90%)
Titan Company3,647.0545.50 (1.26%)
Ultratech Cement9,463.95-38.25 (-0.40%)
Wipro448.60-10.65 (-2.32%)

Pfizer

BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | SECTOR: Major Drugs

₹4,105.10 3.45 (0.08%)

16 Apr 2024, 09:58 (IST)

  • Open

    4,050.10

  • High

    4,136.50

  • Low

    4,050.10

  • Prev Close

    4,101.65

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    187.80B

  • Volume

    0.45K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    4,130.00

  • Ask

    -
View all metrics

Company Description

  • Major Drugs

  • BSE

    500680

  • NSE

    PFIZER

  • ISIN

    INE182A01018

Pfizer Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company has its own manufacturing facility at Goa. The Company has various independent contract/third party manufacturers based across India. Its product portfolio includes vaccine, anti-infectives, cardiac, pain, maternal nutrition, gastrointestinal, contraceptives, anti-inflammatory, nutrition and immunity, and respiratory. The Company's vaccine business is focused on Prevenar 13, a pneumococcal conjugate vaccine that is administered to infants who are six weeks and older as part of primary vaccination, toddlers, adolescents, adults, and elderly population. Its inflammation and immunology portfolio includes two advanced therapies, which cater to patients suffering from diseases related to chronic immune system such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.

Company Officers

  • Amit Agarwal

    Chief Financial Officer, Finance Director, Additional Director(Whole-time Director)

  • Meenakshi Nevatia

    Managing Director, Additional Executive Director

  • P Rengan

    Additional Executive Director - Plant Operations

  • Shilpi Singh

    Director - People Experience

  • Sharad Goswami

    Senior Director - Policy and Public Affairs

  • Pankaj Gupta

    Senior Director - Medical Affairs

  • Aditi Mehta

    Category Lead - Vaccines

  • Manish Paliwal

    Director - Regulatory Affairs

  • Anil Pattanshetty

    Senior Director - Business Operations

  • Shilpa Pradhan

    Category Lead - Hospitals and Neighboring Markets